A
Arine
Optimizes medication to ensure each patient is on the safest, most effective therapy for their unique health needs
About Arine
Arine.io is a healthcare technology startup focused on optimizing medication management to improve patient outcomes and reduce healthcare costs. The company operates in the healthcare sector, specifically targeting older adults and individuals with poor health status who require complex medication regimens. Arine's platform leverages data-driven, predictive analytics and robust evidence to provide personalized medication therapy management (MTM). This approach ensures that medications are used safely and effectively, tailored to each patient's unique health profile.
Arine's primary clients include healthcare providers, insurance companies, and health plans that aim to enhance the quality of care they deliver. By partnering with these organizations, Arine helps improve their performance metrics, such as CAHPS (Consumer Assessment of Healthcare Providers and Systems) ratings and Star ratings, which are critical indicators of patient satisfaction and care quality.
The company's business model revolves around a subscription-based service where healthcare organizations pay for access to Arine's platform and its suite of tools. These tools include comprehensive medication management, medication intelligence, and medication optimization services. Arine generates revenue by providing these services, which help their clients achieve better health outcomes for their patients, thereby reducing overall healthcare costs.
Arine's innovative use of technology in medication management positions it as a leader in the field of personalized medicine. By ensuring that patients receive the right medications at the right doses, Arine not only enhances patient health but also contributes to the financial efficiency of healthcare systems.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- San Francisco, United States
- Employees
- 361
- Open positions
- 8
- Dealroom signal
- 39.5/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Core AI, Hard Tech, AI Applications
- Technology
- Artificial Intelligence
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jun 2025 | $30M | $120M | Kaiser Permanente Ventures · Town Hall Ventures | ↗ |
| DEBTDebt | Aug 2022 | $11M | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Arine is 9K monthly website visits, up 12.5% over the last three months. Arine's team grew 268.4% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
OculusmaximaOculus Maxima: AI-driven telemedicine for eye exams |
Nottingham, United Kingdom | Operational | — | $92K | — |
IMU BiosciencesAI-powered platform decoding the immune system |
London, United Kingdom | Operational | |||
PicturaBioBuilding instant pathogen tests using super-resolution microscopy and machine learning |
Oxford, United Kingdom | Operational | |||
WatcherrAn AI health business solution for senior homes, residences and others |
Aalst, Belgium | Operational | |||
Microplate DxRapid diagnostic platform for antibiotic susceptibility testing |
Glasgow, United Kingdom | Operational | |||
UnforgedDigital mental wellness for Gen Z-centric organisations |
London, United Kingdom | Operational | |||
ElevateMeAt-home blood tests with personalized AI-driven health insights |
London, United Kingdom | Operational | |||
Antidote HealthOffers an AI-based health platform that helps people receive proper medical treatment |
New York City, United States | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
111° West Capital
Katalyst Ventures
Magellan Health Services
SCAN Group
Super Capital Group
New Leaf Venture Partners
MBX Capital
Series B and later2 investors entered at this stage
Town Hall Ventures
Kaiser Permanente Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Arine on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arine’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







